Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer

Clin Lung Cancer. 2003 Nov;5(3):187-9. doi: 10.3816/CLC.2003.n.033.

Abstract

We describe a case of severe hyponatremia following chemotherapy administration in a patient with small-cell lung cancer. There was no evidence of the syndrome of inappropriate antidiuretic hormone (SIADH) secretion. The clinical and laboratory findings were consistent with a sodium-wasting nephropathy complicating cisplatin administration. There are few well-documented reports of cisplatin-associated hyponatremia in the medical literature. We have summarized the relevant literature and attempted to define the differential diagnosis of hyponatremia in this setting. Most cases are accounted for by sodium-losing nephropathy of SIADH, but many reported cases contain insufficient data for classification. Appropriate attention to the evaluation of hyponatremia following platinum-based chemotherapy is needed to properly treat these conditions.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Biomarkers / blood
  • Blood Urea Nitrogen
  • Carcinoma, Small Cell / blood
  • Carcinoma, Small Cell / drug therapy*
  • Cisplatin / adverse effects*
  • Creatinine / blood
  • Diagnosis, Differential
  • Humans
  • Hyponatremia / blood
  • Hyponatremia / chemically induced*
  • Hyponatremia / diagnosis*
  • Inappropriate ADH Syndrome / blood
  • Inappropriate ADH Syndrome / chemically induced
  • Inappropriate ADH Syndrome / diagnosis
  • Kidney Diseases / blood
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / diagnosis*
  • Lung Neoplasms / blood
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Sodium / blood
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Biomarkers
  • Sodium
  • Creatinine
  • Cisplatin